Emeis Stock Drops 3% and Falls Below its MM50, Bucking the Trend of the SBF 120
The health services group's stock significantly drops during the session, going against the grain of a rising Parisian market. The stock falls back into the red after a brief rebound last week, amid a rotation into cyclical stocks.
The Stock Falls Below its MM50 and Is Among the Biggest Declines in the SBF 120
Emeis stock loses 3.15% to €14.16, while the SBF 120 gains 0.70%. This decline places the stock among the biggest drops in the index, alongside Soitec and Medincell, which also fell by more than 3%. This move is part of a turbulent sequence: the stock had already lost 2.5% on Monday, erasing the rebound that began on June 25. Over a month, the performance shows a decline of 4.2%, despite a gain of more than 28% over a year.
Today's slide brings the price back below the MM50 at €14.43 (a gap of -1.87%), while the stock still remains above its MM20 at €14.03 and its MM200 at the same level. The RSI at 56 stays in a neutral zone, with no signs of excess. The support level at €13.64, already tested on June 24, becomes the short-term reference level again if the selling pressure continues.
A Governance Transition Context, Without Immediate Result Catalysts
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The company announced on June 30 four appointments to its executive committee, effective from September and October 2026. These organizational changes are part of the transformation initiated by the former Orpea four years ago, under the presidency of Guillaume Pepy. Today's session does not directly link the stock movement to this announcement, which was already absorbed the day before.
The market context remains favorable for the Parisian marketplace, with the CAC 40 up 0.72% at 8,397 points, following a slowdown in Eurozone inflation to 2.8% in June according to Eurostat. However, Emeis moves against the trend, in a pattern where the stock alternates between rebounds and setbacks since mid-June. The holding of the support at €13.64 will be the next technical reference to watch if the decline continues.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.